Clinical trials
Completed Noncommunicable Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
68 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 9 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 7 |
| 2021 | 7 |
| 2022 | 6 |
| 2023 | 10 |
| 2024 | 5 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 68 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Johns Hopkins Bloomberg School of Public Health | 11 |
| Chinese University of Hong Kong | 4 |
| University of Aarhus | 3 |
| University of North Carolina, Chapel Hill | 3 |
| Harvard School of Public Health (HSPH) | 2 |
| Singapore ETH Centre | 2 |
| American University of Beirut Medical Center | 1 |
| Asfendiyarov Kazakh National Medical University | 1 |
| Asir John Samuel | 1 |
| Bahir Dar University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Noncommunicable Diseases | 68 |
| Hypertension | 10 |
| Diabetes Mellitus | 9 |
| Obesity | 6 |
| Cardiovascular Diseases | 5 |
| Acquired Immunodeficiency Syndrome | 4 |
| Chronic Disease | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Overweight | 3 |
| Stroke | 3 |
Trials
Showing 76 to 68 of 68. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.